Viekira Pak is a Kit in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is .
Product ID | 0074-3093_72523e58-d587-39a6-7c7b-ca6daccb8f69 |
NDC | 0074-3093 |
Product Type | Human Prescription Drug |
Proprietary Name | Viekira Pak |
Generic Name | Dasabuvir And Ombitasvir And Paritaprevir And Ritonavir |
Dosage Form | Kit |
Marketing Start Date | 2014-12-19 |
Marketing Category | NDA / NDA |
Application Number | NDA206619 |
Labeler Name | AbbVie Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-12-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206619 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-12-19 |
Marketing Category | NDA |
Application Number | NDA206619 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-12-19 |
SPL SET ID: | ab74e474-9fd6-902c-9bd9-16dc9541edd0 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0074-3093 | Viekira Pak | Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir |
0074-0063 | Viekira | Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIEKIRA PAK 86425792 4788976 Live/Registered |
AbbVie Inc. 2014-10-16 |